Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Laabs Amanda H., holds the title of Chief Product Officer at Medline Inc..
On 2026-11-12, the insider transacted 520,127 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Laabs Amanda H. (Chief Product Officer) was granted $0 of $MDLN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.